Lisa Haddad, MD, MS, MPH, Emory University

This cross-sectional study sought to determine factors associated with sterilization among HIV-positive US women. HIV-positive women aged 18–45 completed an Audio Computer Assisted Self Interview (ACASI) questionnaire. Chi-square tests and multivariable logistic regression evaluated factors associated with sterilization. The median age of the 187 participants was 37, the majority had at least a high school ...Read more >

Jennifer Robinson, MD, MHS, MPH, John Hopkins University

This study is a formal comparison of the contraceptive knowledge, attitudes, and experiences of HIV-positive adolescent females with those of their HIV-negative peers. We hypothesize that the presence of HIV – a chronic illness that requires lifelong management – will be associated with lower contraceptive adherence and different perceived barriers to successful contraceptive use than ...Read more >

Mya Zapata, MD, MSc, University of Michigan

The purpose of this pilot study is to explore the impact of physician self disclosure (PSD) of personal intrauterine contraception (IUC) use during contraceptive counseling. We hypothesize that PSD of IUC use positively impacts patients during contraceptive counseling. To study this we will conduct a prospective randomized block design pilot trial at the University of ...Read more >

Amy Bryant, MD, University of North Carolina at Chapel Hill

The copper intrauterine device (IUD) is a safe, long-acting, and effective method of contraception that is under-utilized in many countries, including Malawi. A unique cohort of women who had enrolled in a trial of postpartum IUD use one year earlier gave insights into reasons for using, discontinuing, or not using the IUD. We conducted in-depth ...Read more >

Jody Steinauer, MD, MAS, University of California, San Francisco

Background: Women undergoing abortion are at high risk of poor contraceptive use and future unintended pregnancy. We sought to to investigate whether an informational phone call three weeks after having an abortion would improve contraceptive use six weeks after the procedure. Methods: This was a single-blinded, randomized controlled trial in women who chose a combined ...Read more >

Jillian Henderson, PhD, University of California, San Francisco

Background: With the historic legalization of abortion in Nepal in 2002, descriptive data on the prevalence of legal abortion services are now available, but little is known about access to contraception and method use, or reproductive behaviors and intentions following abortion. Our mixed-method study examined women’s contraceptive use and continuation after obtaining a legal abortion, ...Read more >

Rebecca Allen, MD, MPH, Women and Infants Hospital

Background: The intrauterine device is a long-acting, highly effective, reversible contraceptive that may be underutilized due to fear of pain during insertion. To date, in clinical trials, misoprostol, nonsteroidal anti-inflammatory drugs, paracervical block, and 1 mL of 2% lidocaine gel have been found to be ineffective. Methods: This is a randomized, placebo-controlled, double-blind trial evaluating ...Read more >

Julia Steinberg, PhD, University of California, San Francisco

Background: While prior research has shown that psychological health prior to an abortion is a strong predictor of post-abortion mental health and coping, research understanding the role of psychological health in other important post-abortion outcomes, such as contraceptive decision-making is lacking. Objective: The goal of this research is to examine how women’s levels of depression, ...Read more >

Wendy V. Norman, MD, MHSc, University of British Columbia

Background: In Canada, 35.5% of all induced abortions are repeat abortions. To prevent recurrent unintended pregnancy, our service offers a copper intrauterine device (IUD), placed at the time of first trimester abortion. Our six year retrospective review indicated higher than expected one and five year repeat abortion rates among women with an IUD placed at ...Read more >

Cassing Hammond, MD, Northwestern University

Objectives: Despite data suggesting a relationship between HIV transmission and hormonal contraception, prior studies have only investigated the mechanism of hormonal influence at the level of the vaginal epithelium, neglecting genital mucus. The Levonorgestrel-Intrauterine System (Mirena, LNG-IUS) exerts contraceptive action by thickening cervical mucus. Changes in cervical mucus induced by the LNG-IUS might impact HIV ...Read more >